Henrietta Lacks

Henrietta Lacks, a Black tobacco farmer from Virginia, built one of the central tools of twentieth- and twenty-first-century medicine: the living cell line known as HeLa, taken from her cervical tumor in 1951 and still used worldwide in research today. Her cells enabled breakthroughs in polio vaccination, cancer treatment, virology, toxicology, and gene mapping, yet for decades her name and person were erased while institutions and researchers built careers and fortunes on the tissue taken from her without her knowledge or consent. What medicine calls “HeLa” is inseparable from Henrietta Lacks’ body and story; the archive treats the cell line as her authored legacy, not an anonymous raw material.

1.Life and the Making of HeLa

Henrietta Lacks was born Loretta Pleasant in Roanoke, Virginia, in 1920 and grew up in a Black farming community in Clover, Virginia, part of a post‑emancipation rural world where Black families built lives on tobacco land under Jim Crow constraint.

In 1951, while living near Baltimore and seeking care at Johns Hopkins Hospital—one of the few institutions that treated Black patients in segregated Maryland—she was diagnosed with an aggressive cervical cancer. During her treatment, samples of her tumor were taken and passed, without her knowledge or consent, to a research lab run by Dr. George Gey, who had been trying unsuccessfully for years to grow human cells continuously in culture. Where other samples died, Lacks’ cancer cells divided rapidly and seemingly without limit, becoming what the lab labeled “HeLa,” short for “Henrietta Lacks.” The act of naming folded her identity into an acronym while obscuring her person; for decades, the standard record referred to her only by pseudonyms like “Helen Lane.”

Her everyday life—as a mother of five, a neighbor, a churchgoer—was chronicled not in medical charts but in oral histories, funeral programs, and Black family archives. These sources, gathered later by her descendants and Black scholars, restore the person behind the cell line and document a woman who worked, worshipped, and raised children in a segregated city while unknowingly becoming central to global science.

2.What HeLa Built for Medicine

Once Gey’s lab realized that HeLa cells could be kept alive and growing indefinitely, they became the backbone of an emerging biomedical research economy built on cell culture. HeLa cells were used to test the Salk polio vaccine, dramatically accelerating trials and contributing to the vaccine’s success; they became standard tools for studying cancer biology, radiation effects, viral infection, and drug toxicity.

Over the following decades, HeLa cells powered research into HIV, HPV, gene mapping, space biology, and countless drugs; their robustness made them both indispensable and infamous, as they contaminated other cell lines and reshaped how labs handled tissue. This cascade of advances—vaccines, chemotherapies, screening tools—rested on the continuous division of Henrietta Lacks’ cells, which turned her tissue into an industrial‑scale research instrument.

The archive recognizes this instrument as authored: Henrietta Lacks’ biology, her specific tumor and cell behavior, created possibilities that existing techniques had not. The dominant telling, which credits laboratories and principal investigators while treating the cells as an anonymous natural resource, underplays the foundational role of the person whose tissue made those labs’ work possible.

3.Erasure, Misattribution, and Racial Hierarchy in Consent

For more than twenty years after her death in 1951, Henrietta Lacks’ name was largely absent from scientific publications that relied on HeLa. Researchers, institutions, and companies shared, sold, and shipped HeLa cells worldwide, building careers and products, while the Lacks family remained in Baltimore with little or no knowledge of what had been done with her tissue.

Medical literature masked her identity under false names, and mainstream accounts framed HeLa as an abstract tool, not as a Black woman’s living cells. This erasure followed a broader pattern documented in Black hospital records, segregated ward accounts, and testimonies in works like the United States Public Health Service studies in Tuskegee: Black patients and bodies were used in research with limited consent, minimal explanation, and no share in the resulting credit or profit.

When her family began to understand the scale of HeLa’s use in the 1970s, they encountered scientific institutions that had already incorporated her cells into standard practice without any mechanism for recognition, governance, or compensation. Their interviews, church meeting minutes, and Black press coverage chart a story in which a Black family learns that laboratories around the world are using their mother’s cells while they struggle with medical bills and limited access to care.

4.Black Archives, Descendants, and the Re‑Centering of Henrietta Lacks

It was largely through the work of the Lacks family, Black journalists, and later writers and scholars working closely with them that Henrietta Lacks moved from the margins of the HeLa story to its center. Family oral histories, photographs preserved in private collections, and church records documented her life and emphasized that she was not a passive object but a woman embedded in Black community.

These testimonies, admitted here on their own evidentiary standing, pushed institutions to acknowledge her. In the 21st century, after public campaigns and negotiations, research organizations began to formally recognize the Lacks family as stakeholders in the use of HeLa cells, including agreements over genomic data access and ceremonies honoring her contribution. The archive reads these acts not as gifts from institutions but as delayed recognitions of authorship.

Black‑authored scholarship also reframed the narrative: instead of treating HeLa as a case of “medical curiosity,” these works situated Lacks within a lineage of Black patients whose treatment and bodies built medical knowledge while their autonomy was constrained. They connect her story to enslaved medical experimentation, segregated ward practices, and systemic exclusion from patent and profit systems, showing that the lack of formal credit is a structural outcome, not evidence that she did not author the tools.

5.Ongoing Questions: Ownership, Ethics, and Authorship in Tissue

Henrietta Lacks’ case continues to shape debates over tissue ownership, informed consent, and justice in research. Courts and standard legal doctrine often hold that once tissue is removed, patients have limited control over its use. The archive notes that such doctrine emerged in a context where Black and poor patients were least able to negotiate consent and most likely to have their bodies turned into resources without compensation.

By foregrounding Lacks as an author of the cell line and its consequences, the archive challenges the idea that scientific credit belongs only to researchers and institutions. Her story prompts a re‑evaluation of who is named in discovery narratives and whose contributions—biological, experiential, and testimonial—are acknowledged. The questions raised by HeLa are not closed: they continue to inform community‑based research ethics, demands for shared governance over data and biospecimens, and the insistence that Black participation in science must be valued as co‑creation, not extraction.

In this record, Henrietta Lacks stands not merely as a patient exploited by systems, but as a central figure whose cells changed the world and whose descendants forced medicine to reckon with the moral and racial terms under which that change occurred.

The family archive is admissible here. Photographs, letters, deeds, church programs, funeral bulletins, business records, recordings — the things that were kept when no institution was keeping them. A keeper reviews everything before it is admitted, and your name stays on it.

7.References